
Home » HELIX BIOMEDIX REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS
HELIX BIOMEDIX REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS
May 12, 2006
Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the first quarter ended March 31, 2006. For the first quarter of 2006, Helix BioMedix reported a net loss of $822,300, or $0.04 per diluted share, compared to a net loss of $765,800, or $0.05 per diluted share, in the comparable prior year period.
Yahoo News (http://biz.yahoo.com/prnews/060512/sff018.html?.v=51)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr